Schneider et al. studied the biological function of DLGAP5 in non-small cell lung cancer; through RT-qPCR and immunofluorescence, it was shown that DLGAP5 is more highly expressed in lung cancer tissues than in normal lung tissues and is associated with poor prognosis [20]. Here, DLGAP5 is linked to non-small cell lung carcinoma.